Dannah McKellar Ntaka
@mckellardan.bsky.social
McKellar Ntaka is a clinical researcher who focuses on healthy outcomes for mothers and babies. She possesses 29 years experience in maternal health research with concentrations in microbiology and pelvic anatomy and physiology.
Reposted by Dannah McKellar Ntaka
90% of people diagnosed with pancreatic cancer die from the disease. That's why the medical community is excited about the results of a small trial in which nearly half of the pancreatic cancer patients who received an mRNA vaccine for the disease remained relapse-free three years later.
A Vaccine For Pancreatic Cancer Continues To Show Promise
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.
www.sciencefriday.com
March 16, 2025 at 2:09 PM
90% of people diagnosed with pancreatic cancer die from the disease. That's why the medical community is excited about the results of a small trial in which nearly half of the pancreatic cancer patients who received an mRNA vaccine for the disease remained relapse-free three years later.